Data / Form D filings / Pocket Naloxone Corp.
Pocket Naloxone Corp.: Form D filings
Pocket Naloxone Corp., a pharmaceuticals company in Bethesda, MD, filed 2 Form D notices with the SEC in 2021. The latest, on September 2, 2021, reports $6.2 million sold of a $7.1 million offering to 65 investors.
Find out what Pocket Naloxone Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4701 Sangamore Road, Bethesda, MD, 20816
- Phone
- (301) 818-9810
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1847131
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 2, 2021 | Amendment | $7,121,169 | $6,163,967 | $957,202 | 65 | Mar 15, 2021 | sec.gov |
| Feb 23, 2021 | New notice | $2,500,000 | $0 | $2,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrea Barthwell | Director | |
| Behshad Sheldon | Director | |
| Ashanthi Mathai | Executive Officer, Director | |
| Serena Kim | Executive Officer | |
| Kathryn Bowsher | Director |
Every Form D from the week of Aug 30, 2021 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pocket Naloxone Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.